2006: Vanson HaloSource, Inc., begins doing business as “HaloSource” as part of brand strategy focus.
2005: $5 million round of funding received from Mars, Inc.
2004: Vanson HaloSource and Medline sign contract to license HaloShield® for odor-control incontinence pads.
2003: Vanson HaloSource inks deal to license HaloShield™ to Medline for use in hospital linens and scrubs.
2002: Vanson HaloSource closes $9 million in equity. The round was led by Seattle venture capital fund Alexander Hutton Venture Partners. Buerk Dale Victor LLC, Britannia Holdings Ltd. and a small group of individual investors also participated in the round.
2002: Vanson, Inc., and HaloSource Corp. were merged to form Vanson
HaloSource, Inc., in order to expand opportunities for product commercialization.
2001: HaloSource Corporation Named one of the top 25 private Northwest companies in 2001.
2001: Scale-up and plant trials of HaloSource’s HaloPure core chemistry are conducted.
1999: HaloSource Corporation received venture capital investments to commercialize core antimicrobial technology in fields of water purification and infectious disease control.
1998: HaloSource Corporation was founded in Seattle, Washington, and secured worldwide licenses to patented core N-halamine technology from Auburn University and University of California.
1997: Vanson Associates Limited Partnership was incorporated as Vanson, Inc., in the state of Washington.
1995: Vanson Associates Limited Partnership was formed to purchase selected assets back from DCV.
1988: DCV, a DuPont/Con Agra jointly owned company, acquired certain assets of MCR.
1982: MCR Chitosan Associates Limited Partnership was formed to build a chitin-processing plant in Raymond, Washington.
